News
MMSI
87.08
+0.09%
0.08
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Ocular Therapeutix (OCUL) and Repare Therapeutics (RPTX)
TipRanks · 1d ago
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
NASDAQ · 1d ago
Weekly Report: what happened at MMSI last week (0715-0719)?
Weekly Report · 3d ago
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date. Med-tech was up 3.4% and the U.S. Health care sector was up 8.8%.
Seeking Alpha · 6d ago
Aristotle Capital Small/Mid Cap Equity Q2 2024 Commentary
Seeking Alpha · 07/18 11:40
Insiders At Merit Medical Systems Sold US$556k In Stock, Alluding To Potential Weakness
Merrit Medical Systems, Inc. Insiders sold US$479k worth of shares in the last year. The biggest insider sale was by the CFO & Treasurer of the company, Raul Parra, for US$74.52 per share. Merit Medical systems insiders own 2.3% of the Company. The last year of insider transactions don't fill us with confidence. You can see the insider transactions of Merit medical Systems over the past year.
Simply Wall St · 07/16 19:42
What 9 Analyst Ratings Have To Say About Merit Medical Systems
9 analysts have expressed a variety of opinions on Merit Medical Systems (NASDAQ:MMSI) over the past quarter. The company is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology and endoscopy. The average price target of 12-month price targets is $99.78, with a high estimate of $125.00.
Benzinga · 07/16 14:00
Merit Medical Is Maintained at Outperform by Barrington Research
Dow Jones · 07/16 13:24
Merit Medical Price Target Maintained With a $100.00/Share by Barrington Research
Dow Jones · 07/16 13:24
Buy Rating Affirmed for Merit Medical on Strong Growth and Profitability Prospects
TipRanks · 07/16 13:15
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $100 Price Target
Benzinga · 07/16 13:13
Weekly Report: what happened at MMSI last week (0708-0712)?
Weekly Report · 07/15 09:22
Weekly Report: what happened at MMSI last week (0701-0705)?
Weekly Report · 07/08 09:23
Merit Medical Systems: Steady Wins The Day
Seeking Alpha · 07/05 19:58
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
NASDAQ · 07/04 16:15
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
NASDAQ · 07/03 16:23
Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Mmerit Medical Systems's (NASDAQ:MMSI) stock increased by 19% over the past three months. Merit Medical systems has a return on equity of 8.2%. The company grew its net income at a rate of 44% in the last five years. The company's ROE is a good indicator of its ability to reinvest in its business. It has a similar ROE to the average for its industry.
Simply Wall St · 07/03 10:34
Merit Medical Is Maintained at Outperform by Barrington Research
Dow Jones · 07/02 18:49
Merit Medical Price Target Maintained With a $100.00/Share by Barrington Research
Dow Jones · 07/02 18:49
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $100 Price Target
Benzinga · 07/02 18:40
More
Webull provides a variety of real-time MMSI stock news. You can receive the latest news about Merit Med Sys Inc through multiple platforms. This information may help you make smarter investment decisions.
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.